These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Macrophage activation: a riddle of immunological resistance. Crawford RM; Leiby DA; Green SJ; Nacy CA; Fortier AH; Meltzer MS Immunol Ser; 1994; 60():29-46. PubMed ID: 8251575 [TBL] [Abstract][Full Text] [Related]
24. In the absence of endogenous gamma interferon, mice acutely infected with Neospora caninum succumb to a lethal immune response characterized by inactivation of peritoneal macrophages. Nishikawa Y; Tragoolpua K; Inoue N; Makala L; Nagasawa H; Otsuka H; Mikami T Clin Diagn Lab Immunol; 2001 Jul; 8(4):811-6. PubMed ID: 11427432 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. Hübel K; Dale DC; Liles WC J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286 [TBL] [Abstract][Full Text] [Related]
26. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines. Kelley VE; Fiers W; Strom TB J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799 [TBL] [Abstract][Full Text] [Related]
28. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. O'Sullivan ST; Lederer JA; Horgan AF; Chin DH; Mannick JA; Rodrick ML Ann Surg; 1995 Oct; 222(4):482-90; discussion 490-2. PubMed ID: 7574928 [TBL] [Abstract][Full Text] [Related]
29. Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns. García VE; Quiroga MF; Ochoa MT; Ochoa L; Pasquinelli V; Fainboim L; Olivares LM; Valdez R; Sordelli DO; Aversa G; Modlin RL; Sieling PA J Immunol; 2001 Nov; 167(10):5719-24. PubMed ID: 11698444 [TBL] [Abstract][Full Text] [Related]
30. CD154 activates macrophage antimicrobial activity in the absence of IFN-gamma through a TNF-alpha-dependent mechanism. Andrade RM; Wessendarp M; Subauste CS J Immunol; 2003 Dec; 171(12):6750-6. PubMed ID: 14662879 [TBL] [Abstract][Full Text] [Related]
31. Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense. In vitro, in animal models, and in humans. Murray HW Diagn Microbiol Infect Dis; 1990; 13(5):411-21. PubMed ID: 2126500 [No Abstract] [Full Text] [Related]
32. Therapeutic effect of interferon-gamma gene transfer in experimental visceral leishmaniasis. Taylor AP; Murray HW J Infect Dis; 1998 Sep; 178(3):908-11. PubMed ID: 9728571 [TBL] [Abstract][Full Text] [Related]
33. Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. Jaffe HA; Buhl R; Mastrangeli A; Holroyd KJ; Saltini C; Czerski D; Jaffe HS; Kramer S; Sherwin S; Crystal RG J Clin Invest; 1991 Jul; 88(1):297-302. PubMed ID: 1905329 [TBL] [Abstract][Full Text] [Related]
34. Cytokines as antimicrobial therapy for the T cell-deficient patient: prospects for treatment of nonviral opportunistic infections. Murray HW Clin Infect Dis; 1993 Nov; 17 Suppl 2():S407-13. PubMed ID: 8274606 [TBL] [Abstract][Full Text] [Related]
36. Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis. Murray HW J Infect Dis; 1990 May; 161(5):992-4. PubMed ID: 2157773 [TBL] [Abstract][Full Text] [Related]
37. Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-γ. Cabral-Marques O; Ramos RN; Schimke LF; Khan TA; Amaral EP; Barbosa Bomfim CC; Junior OR; França TT; Arslanian C; Carola Correia Lima JD; Weber CW; Ferreira JF; Tavares FS; Sun J; D'Imperio Lima MR; Seelaender M; Garcia Calich VL; Marzagão Barbuto JA; Costa-Carvalho BT; Riemekasten G; Seminario G; Bezrodnik L; Notarangelo L; Torgerson TR; Ochs HD; Condino-Neto A J Allergy Clin Immunol; 2017 Mar; 139(3):900-912.e7. PubMed ID: 27554817 [TBL] [Abstract][Full Text] [Related]
38. The role of gamma interferon in antimicrobial immunity. Shtrichman R; Samuel CE Curr Opin Microbiol; 2001 Jun; 4(3):251-9. PubMed ID: 11378475 [TBL] [Abstract][Full Text] [Related]
39. Controlled clinical trial of interferon-gamma as postoperative surgical adjuvant therapy for colon cancer. Wiesenfeld M; O'Connell MJ; Wieand HS; Gonchoroff NJ; Donohue JH; Fitzgibbons RJ; Krook JE; Mailliard JA; Gerstner JB; Pazdur R J Clin Oncol; 1995 Sep; 13(9):2324-9. PubMed ID: 7666090 [TBL] [Abstract][Full Text] [Related]
40. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. Nathan CF; Murray HW; Wiebe ME; Rubin BY J Exp Med; 1983 Sep; 158(3):670-89. PubMed ID: 6411853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]